Tirzepatide 5MG
$50.00
9 in stock
Description
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It supports research into glucose regulation, insulin sensitivity, weight management, and metabolic health.
Product Details
- Concentration: 10mg per vial
- Purity: ≥99% (COA verified)
- Manufacturing: USA, GMP-certified facility
- Format: Lyophilized powder for reconstitution
- Research Use Only
Product Care
- Store refrigerated at 36°F to 46°F (2°C to 8°C)
- Keep in the original container, protected from light.
- Once reconstituted, use within the recommended timeframe.
Product Note
This product is intended for research. Not for unsupervised or recreational use.
The Science
Tirzepatide is a first-in-class dual agonist that activates both GIP and GLP-1 receptors. By engaging these pathways, it has been shown in research to enhance insulin secretion, improve glycemic control, reduce appetite, and promote weight reduction. Its unique mechanism makes it an advanced tool in studies of obesity, type 2 diabetes, and metabolic syndrome.
